Roche’s virtual analyst event during ESMO IO

Roche has hosted a virtual event on Friday, 10 December 2021.

 

Agenda

  • Welcome
    Karl Mahler, Head of Investor Relations
  • CITYSCAPE updated analysis: Tiragolumab + Tecentriq in 1L NSCLC
    Raymond Meng, M.D., Ph.D. - Global Development Leader Tiragolumab
  • Tiragolumab development overview
    Heather Stevens, MBA, MPH - Life Cycle Leader, Tiragolumab
  • Q&A
 

Please register to access the replay*

* Privacy notice 

 

Live Webinar Replay

* Mandatory

 

The registration form for the webcast is not available.

 

Please come back 30 minutes before the webcast start date and fill in the registration form.